DUBLIN, Oct. 7, 2022 /PRNewswire/ Endo International plc (OTC: ENDPQ) announced today that data from studies of Endo Aesthetics' Qwo (collagenase clostridium histolyticum-aaes), an FDA-approved
DUBLIN, March 2, 2022 /PRNewswire/ Endo International plc (NASDAQ: ENDP) has kicked off a series of more than 200 patient events that will be held across the United States as part of Butt
/PRNewswire/ Endo International plc (NASDAQ:ENDP) announced today that data from clinical and non-clinical studies of Endo Aesthetics Qwo® (collagenase.